The Institute for Genomic Research Duke University Boston University The Jackson Laboratory Medical College of Wisconsin University of Pennsylvania
What's New
Description
Contacts
Data
Analysis Tools
Targets
Protocols
Outreach
NHLBI Participants
Contact Us

NHLBI PGA Participants

Initial sequencing of the human genome ‚ the first step in the full decoding of the genome ‚ is nearing completion. To optimally apply this knowledge, however, scientists must still decipher many of the individual genes and their specific functions. The purpose of the PGAs is to identify the human genes particularly relevant to heart, lung, blood, and sleep functions by expanding upon the data and technologies developed to map and sequence the human genome.

Participants in the NHLBI PGA program include:

BayGenomics
The NHLBI Bay Area Functional Genomics Consortium
J. David Gladstone Institutes
Dr. Stephen G. Young

Berkeley PGA
Comparative Genomic Analysis Of Cardiovascular Gene Regulation
Lawrence Berkeley National Laboratory
Dr. Edward M. Rubin
 
CardioGenomics
Genomics Of Cardiovascular Development, Adaptation And Remodeling
Harvard Medical School-Beth Israel Deaconess Medical Center
Dr. Seigo Izumo
 
HopGenes
Applied Genomics In Cardiopulmonary Disease
Johns Hopkins University
Dr. Joe G.N. Garcia
 
InnateImmunity
Innate Immunity In Heart, Lung, And Blood Disease
University of Arizona
Dr. Fernando D. Martinez

JAX PGA
Mouse Models Of Heart, Lung, And Blood Diseases
Jackson Laboratory
Dr. Luanne L. Peters
 
ParaBioSys
Genomic Analysis Of Stress And Inflammation
Massachusetts General Hospital
Dr. Brian Seed
 
PhysGen
Physiogenomics Of Stressors In Derived Consomic Rats
Medical College of Wisconsin
Dr. Howard J. Jacob
 
SeattleSNPs
UW-FHCRC Variation Discovery Resource
University of Washington
Dr. Deborah A. Nickerson
 
Southwestern
Genomics And Proteomics Of Cell Injury And Inflammation
University of Texas Southwest Medical Center/Dallas
Dr. Stephen A. Johnston

TREX
Microarray Expression Profiling Of Rodent Models Of Human Disease
The Institute for Genomic Research (TIGR)
Dr. John Quackenbush